Cross-Presenting XCR1<sup>+</sup> Dendritic Cells as Targets for Cancer Immunotherapy.

导出 LinkOut

翻译打印收藏纠错

作者： Katherine M,Audsley ^[1] ; Alison M,McDonnell ^[2] ; Jason,Waithman ^[1]

作者单位： Telethon Kids Institute, University of Western Australia, Perth Children's Hospital, Nedlands, WA 6009, Australia. ^[1] School of Biomedical Sciences, The University of Western Australia, Crawley, WA 6009, Australia. ^[2] National Centre for Asbestos Related Diseases, The University of Western Australia, QEII Medical Centre, Nedlands, WA 6009, Australia. ^[3]

关键词 DC-based therapy cancer cross-presenting dendritic cells immunotherapy

主题词动物(Animals);癌症疫苗(Cancer Vaccines);交叉激活(Cross-Priming);树突细胞(Dendritic Cells);人类(Humans);免疫疗法(Immunotherapy);肿瘤(Neoplasms);受体, G-蛋白偶联(Receptors, G-Protein-Coupled)

DOI 10.3390/cells9030565

PMID 32121071

发布时间 2021-02-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cells

2020年9卷3期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cross-Presenting XCR1<sup>+</sup> Dendritic Cells as Targets for Cancer Immunotherapy.

Cells

相似文献

Cells

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cross-Presenting XCR1<sup>+</sup> Dendritic Cells as Targets for Cancer Immunotherapy.

Cells

相似文献

Cells

相关期刊

检索历史清除